544 related articles for article (PubMed ID: 9130721)
1. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
2. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
3. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
Mayeda A; Helfman DM; Krainer AR
Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
[TBL] [Abstract][Full Text] [Related]
4. Regulated splicing of an alternative exon of beta-tropomyosin pre-mRNAs in myogenic cells depends on the strength of pyrimidine-rich intronic enhancer elements.
Pret AM; Balvay L; Fiszman MY
DNA Cell Biol; 1999 Sep; 18(9):671-83. PubMed ID: 10492398
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific splicing of two mutually exclusive exons of the chicken beta-tropomyosin pre-mRNA: positive and negative regulations.
Gallego ME; Sirand-Pugnet P; Durosay P; Clouet d'Orval B; d'Aubenton-Carafa Y; Brody E; Expert-Bezançon A; Marie J
Biochimie; 1996; 78(6):457-65. PubMed ID: 8915535
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA.
Expert-Bezançon A; Le Caer JP; Marie J
J Biol Chem; 2002 May; 277(19):16614-23. PubMed ID: 11867641
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
8. Cis regulating elements which control in vivo alternative splicing of the chicken beta tropomyosin primary transcript.
Fiszman MY; Libri D; Balvay L
Symp Soc Exp Biol; 1992; 46():355-62. PubMed ID: 1341048
[TBL] [Abstract][Full Text] [Related]
9. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon.
Gooding C; Roberts GC; Smith CW
RNA; 1998 Jan; 4(1):85-100. PubMed ID: 9436911
[TBL] [Abstract][Full Text] [Related]
10. cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene.
Gallego ME; Balvay L; Brody E
Mol Cell Biol; 1992 Dec; 12(12):5415-25. PubMed ID: 1280322
[TBL] [Abstract][Full Text] [Related]
11. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
12. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
13. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
[TBL] [Abstract][Full Text] [Related]
14. Sequence divergence associated with species-specific splicing of the nonmuscle beta-tropomyosin alternative exon.
Pret AM; Fiszman MY
J Biol Chem; 1996 May; 271(19):11511-7. PubMed ID: 8626711
[TBL] [Abstract][Full Text] [Related]
15. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
16. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
17. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
[TBL] [Abstract][Full Text] [Related]
18. ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicing.
Crovato TE; Egebjerg J
FEBS Lett; 2005 Aug; 579(19):4138-44. PubMed ID: 16023113
[TBL] [Abstract][Full Text] [Related]
19. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
